PRKAR1A and ovarian cancer: Recently, TSE1 was found to suppress the sphere forming and invasion activity of Aldehyde dehydrogenase (ALDH)-positive ovarian cancer stem-like cells (CSCs), which contribute to tumor growth, recurrence and chemoresistance [26].